Publications

  • A Path to Faster Growth for Healthcare Companies: Eliminate Complexity

    November 08, 2017 | Bain Brief

    Healthcare manufacturers have long believed that all revenue growth is good. But to increase the top line, many launched new products without addressing legacy versions, entered new categories without a path to leadership and expanded to all corners of the world without sufficient local scale.

  • How to Make Your Drug Launch A Success

    October 23, 2017 | IN VIVO

    The pain is becoming all too common for many pharmaceutical executives. After a decade or more of investment in drug development and clinical trials, a company launches a promising new product only to see sales fall far short of expectations.

  • Doctors Feel Excluded from Health Care Value Efforts

    October 06, 2017 | HBR.org

    Health care organizations can generate greater support for value-based care by working closely with their physicians to shape models and addressing doctors’ concerns about implementation and outcomes.

  • Trump Slows Efforts to Cut Health-Care Costs

    October 05, 2017 | Healthcare | Bloomberg Businessweek | Media mention

    New payment models may allow the most efficient health-care providers to boost their profits while reducing overall costs. But ultimately someone will have to take a financial hit, according to Joshua Weisbrod, a partner with Bain & Company.

  • Why Leading Medtech Companies Are Putting Customers Ahead of Products

    September 07, 2017 | Bain Brief

    The leadership team at a global technology company had to move fast. Its products were losing market share as customers switched to integrated solutions. Worse, clients cited the company’s lack of responsiveness as a main reason for switching.

  • How to Make Your Drug Launch a Success

    September 06, 2017 | Pharmaceuticals | Bain Brief

    Bain research shows successful pharmaceutical companies are overhauling their approach to drug launch—and they do three things right.

  • Cooper’s Take: Recession Concerns Take Center Stage for Health-Care Investors

    July 31, 2017 | Healthcare | WSJ Pro | Media mention

    Many health care-focused firms are thinking more about recessionary risks than the health-care debate on Capitol Hill, said Joshua Weisbrod, a partner at Bain & Company. He said his clients are looking at the effects a likely economic downturn would have on the companies they are considering

  • Cooper’s Take: Consumer Health-Care Brings New Players Into the Fray

    June 08, 2017 | Healthcare | Wall Street Journal Pro | Media mention

    According to Nirad Jain, a health care-focused partner at consulting firm Bain & Company, interest in consumer-focused health-care companies may stem from investors bracing for a potential economic downturn.

  • Finding The Right Path To Category Leadership In Oncology

    June 03, 2017 | IN VIVO

    Oncology drug development is undergoing rapid shifts. Bain research shows companies that seek to lead in specific vertical categories outperform rivals that invest across a broad spectrum of cancer targets.

  • Front Line of Healthcare Report 2017: Why involving doctors can help improve US healthcare

    May 11, 2017 | Bain report

    Bringing physicians back into the decision-making process will help create greater momentum for change.